Literature DB >> 19673907

MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women.

M Schürks1, R Y L Zee, J E Buring, T Kurth.   

Abstract

Data on the association of the MTHFR 677C→T and ACE D/I polymorphisms with migraine severity, measured by attack frequency, are scarce. We performed an association study among 24 961 women participating in the Women's Health Study. Migraine, aura status and attack frequency were self-reported. Multinomial logistic regression was used to investigate the genotype-migraine association. Among the 3186 migraineurs with complete genotype and attack frequency data, 1270 reported migraine with aura (MA) (attack frequency 76 ≥ weekly; 219 monthly; 123 every other month; 852 fewer than six times/year) and 1916 migraine without aura (MoA) (attack frequency: 85 ≥ weekly; 414 monthly; 208 every other month; 1209 fewer than six times/year). The MTHFR 677TT genotype was associated with a reduced risk for MA, which only appeared for attacks fewer than six times/year (age-adjusted odds ratio 0.78; 95% confidence interval 0.61, 0.99). We did not find a specific pattern of association of the ACE D/I polymorphism with attack frequency for MA or MoA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19673907      PMCID: PMC2888757          DOI: 10.1111/j.1468-2982.2009.01980.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  43 in total

1.  Migraine and MTHFR C677T genotype in a population-based sample.

Authors:  Ann I Scher; Gisela M Terwindt; W M Monique Verschuren; Mark C Kruit; Henk J Blom; Hisanori Kowa; Rune R Frants; Arn M J M van den Maagdenberg; Mark van Buchem; Michel D Ferrari; Lenore J Launer
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

2.  Metabolic and genetic risk factors for migraine in children.

Authors:  F Bottini; M E Celle; M G Calevo; S Amato; G Minniti; L Montaldi; D Di Pasquale; R Cerone; E Veneselli; A C Molinari
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

3.  Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man.

Authors:  Juei-Jueng Lin; Po-Jen Wang; Chih-Hung Chen; Kuo-Chu Yueh; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Acta Neurol Taiwan       Date:  2005-09

4.  Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele.

Authors:  Agustín Oterino; Natalia Valle; Julio Pascual; Yolanda Bravo; Pedro Muñoz; Jesús Castillo; Carlos Ruiz-Alegría; Pablo Sánchez-Velasco; Francisco Leyva-Cobián; Carmen Cid
Journal:  Brain Res Mol Brain Res       Date:  2005-09-13

5.  Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women.

Authors:  Shumin M Zhang; Steven C Moore; Jennifer Lin; Nancy R Cook; JoAnn E Manson; I-Min Lee; Julie E Buring
Journal:  Am J Epidemiol       Date:  2005-12-07       Impact factor: 4.897

Review 6.  The epidemiology of migraine.

Authors:  Richard B Lipton; Marcelo E Bigal
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

7.  Baseline characteristics of participants in the Women's Health Study.

Authors:  K M Rexrode; I M Lee; N R Cook; C H Hennekens; J E Buring
Journal:  J Womens Health Gend Based Med       Date:  2000 Jan-Feb

Review 8.  Chronic disorders with episodic manifestations: focus on epilepsy and migraine.

Authors:  Sheryl R Haut; Marcelo E Bigal; Richard B Lipton
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

9.  Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.

Authors:  Rod A Lea; Micky Ovcaric; James Sundholm; Leah Solyom; John Macmillan; Lyn R Griffiths
Journal:  Brain Res Mol Brain Res       Date:  2005-02-19

10.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

View more
  9 in total

Review 1.  Identification of molecular genetic factors that influence migraine.

Authors:  Bridget H Maher; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2011-04-26       Impact factor: 3.291

2.  Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role?

Authors:  Ann I Scher; Gudny Eiriksdottir; Melissa Garcia; Preethy Feit; Albert V Smith; Tamara B Harris; Kathryn A Roecklein; Larus S Gudmundsson; Vilmundur Gudnason; Lenore J Launer
Journal:  Cephalalgia       Date:  2012-12-10       Impact factor: 6.292

3.  Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine.

Authors:  Recep Eröz; Anzel Bahadir; Suber Dikici; Sener Tasdemir
Journal:  Neuromolecular Med       Date:  2014-05-22       Impact factor: 3.843

4.  MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.

Authors:  Masakazu Ishii; Shunichi Shimizu; Yuki Sakairi; Ayumu Nagamine; Yuika Naito; Yukiko Hosaka; Yuko Naito; Tatsuya Kurihara; Tomomi Onaya; Hideto Oyamada; Atsuko Imagawa; Kenji Shida; Johji Takahashi; Katsuji Oguchi; Yutaka Masuda; Hajime Hara; Shino Usami; Yuji Kiuchi
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

Review 5.  Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.

Authors:  Md Rafiqul Islam; Dale R Nyholt
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

6.  Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue.

Authors:  Anzel Bahadir; Recep Eroz; Suber Dikici
Journal:  Cell Mol Neurobiol       Date:  2013-08-22       Impact factor: 5.046

7.  Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis.

Authors:  Zainab Samaan; Daria Gaysina; Sarah Cohen-Woods; Nick Craddock; Lisa Jones; Ania Korszun; Mike Owen; Andrew Mente; Peter McGuffin; Anne Farmer
Journal:  BMC Neurol       Date:  2011-06-02       Impact factor: 2.474

8.  Meta-analysis of genome-wide association for migraine in six population-based European cohorts.

Authors:  Lannie Ligthart; Boukje de Vries; Albert V Smith; M Arfan Ikram; Najaf Amin; Jouke-Jan Hottenga; Stephany C Koelewijn; V Mathijs Kattenberg; Marleen H M de Moor; A Cecile J W Janssens; Yurii S Aulchenko; Ben A Oostra; Eco J C de Geus; Johannes H Smit; Frans G Zitman; André G Uitterlinden; Albert Hofman; Gonneke Willemsen; Dale R Nyholt; Grant W Montgomery; Gisela M Terwindt; Vilmundur Gudnason; Brenda W J H Penninx; Monique Breteler; Michel D Ferrari; Lenore J Launer; Cornelia M van Duijn; Arn M J M van den Maagdenberg; Dorret I Boomsma
Journal:  Eur J Hum Genet       Date:  2011-03-30       Impact factor: 4.246

9.  Effects of MTHFR gene polymorphism on the clinical and electrophysiological characteristics of migraine.

Authors:  Julia E Azimova; Alexey V Sergeev; Liubov A Korobeynikova; Natalia S Kondratieva; Zarema G Kokaeva; Gadji O Shaikhaev; Kirill V Skorobogatykh; Natalia M Fokina; Gyusal R Tabeeva; Eugene A Klimov
Journal:  BMC Neurol       Date:  2013-08-05       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.